ornidazole has been researched along with Uterine Cervical Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atkovar, G; Okkan, S; Sahinler, I; Turkan, S; Uzel, R | 1 |
| Akçasu, A; Egehan, I; Hacibekiroğlu, M; Okkan, S; Olgun, P; Turkan, S; Uzel, R; Yazici, Z | 1 |
2 trial(s) available for ornidazole and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
A randomised study of ornidazole as a radiosensitiser in carcinoma of the cervix: long term results.
Topics: Adult; Aged; Female; Humans; Middle Aged; Ornidazole; Radiation-Sensitizing Agents; Survival Rate; Uterine Cervical Neoplasms | 1996 |
Use of ornidazole in fractionated radiotherapy: dose tolerance, serum and tumour tissue concentration.
Topics: Adult; Clinical Trials as Topic; Combined Modality Therapy; Double-Blind Method; Drug Tolerance; Female; Humans; Kinetics; Laryngeal Neoplasms; Male; Nitroimidazoles; Ornidazole; Radiation-Sensitizing Agents; Random Allocation; Uterine Cervical Neoplasms | 1986 |